Hm. Pettinati et al., Sertraline treatment for alcohol dependence: Interactive effects of medication and alcoholic subtype, ALC CLIN EX, 24(7), 2000, pp. 1041-1049
Background: Characteristic behaviors of some alcohol-dependent individuals,
e.g., binge drinking, comorbid psychopathology, and some types of alcohol-
related problems, have been linked to abnormalities in serotonergic neurotr
ansmission. However, studies that have evaluated serotonergic pharmacothera
py for reducing drinking have yielded conflicting results. One explanation
for these findings is a general failure to distinguish alcohol subgroups th
at may be differentiated on the basis of serotonergic abnormalities. Howeve
r, in 1996, Kranzler and colleagues reported that Type B alcoholics, who ar
e characterized by high levels of premorbid vulnerability, alcohol dependen
ce severity, and comorbid psychopathology, showed less favorable drinking o
utcomes in response to treatment with fluoxetine, a serotonin reuptake inhi
bitor, than with placebo. This medication effect was not seen in Type A alc
oholics, i.e., those with lower risk/severity of alcoholism and psychopatho
logy. The aim of the present study was to explore the validity of different
ial responding by alcohol-dependent subtypes using the serotonin reuptake i
nhibitor, sertraline.
Methods: A k-means clustering procedure was applied to a sample of alcohol-
dependent subjects enrolled in a 14-week, placebo-controlled trial of 200 m
g/day of sertraline, classifying them into lower-risk severity (Type A: n =
55) and higher-risk/severity (Type B: n = 45) subgroups.
Results: A significant interaction between alcoholic subtype and medication
condition was found, confirming the findings of Kranzler and colleagues th
at alcoholic subtypes responded differentially to serotonergic medication.
Somewhat at variance with their results, however, the present study showed
that the lower risk/severity (Type A) subjects had more favorable outcomes
when treated with sertraline compared to placebo.
Conclusions: Alcoholic subtypes differentially responded to sertraline when
used as a treatment to reduce alcohol drinking, with one subtype having mo
re favorable outcomes. Subtyping alcoholics may help to resolve conflicting
findings in the literature on serotonergic treatment of alcohol dependence
.